Kashyap Tele-Medicines Share History & Returns 2012 to 2024
Kashyap Tele-Medicines Limited | |||
Price: ₹2.69 | |||
52 Week Low: ₹1.41 52 Week High: ₹3.27 | |||
Market Capital: N/A | |||
-> |
Show Table of Contents
Table of Contents
- 1: Kashyap Tele-Medicines Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Kashyap Tele-Medicines Recent Performance
- 3: Kashyap Tele-Medicines Stock Price Chart From 2012 to 2024
- 4: Kashyap Tele-Medicines Stock Price History Table From 2012 to 2024
- 5: Analyzing the Impact of Investing in Kashyap Tele-Medicines
- 5.1: Kashyap Tele-Medicines Stock Returns In Last 5 Years
- 6: Kashyap Tele-Medicines Returns vs Bank FD Returns
Kashyap Tele-Medicines Stock Highlights
As of 26 Dec 2024, Kashyap Tele-Medicines Stock price is ₹2.69 which is ₹0.58 below 52-week high of ₹3.27 and ₹1.28 above 52-week low of ₹1.41
52-Week High Low
- Kashyap Tele-Medicines 52-Week High is ₹3.27 occurred on 25 Sep 2024
- Kashyap Tele-Medicines 52-Week Low is ₹1.41 occurred on 07 Feb 2024
All Time High
- The all-time high or the highest price that Kashyap Tele-Medicines stocks have ever touched was ₹3.27 and this occurred on 26 Dec 2024.
- The highest closing price at which Kashyap Tele-Medicines stocks have ever closed was ₹2.96 recorded on 26 Dec 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Kashyap Tele-Medicines Recent Performance
Over the past 15 trading days, the value of Kashyap Tele-Medicines's stock has increased by ₹0.71 (+35.86%). On 05 Dec 2024, its one share was worth ₹1.98 and by 26 Dec 2024, the value jumped to ₹2.69. During this period it created a highest high of ₹2.74 and lowest low of ₹1.89.
Click on legend items to show/hide respective price lines
Kashyap Tele-Medicines Stock Price Chart From 2012 to 2024
Click on legend items to show/hide respective price lines
Kashyap Tele-Medicines Stock Price History Table From 2012 to 2024
Year | Kashyap Tele-Medicines | YOY Chg% | ↑High - ↓Low |
---|---|---|---|
2024 | ₹2.69 | 29.9% | ↑ ₹3.27 ↓ ₹1.41 |
2023 | ₹2.07 | 32.6% | ↑ ₹2.80 ↓ ₹1.14 |
2022 | ₹1.56 | 129.4% | ↑ ₹2.69 ↓ ₹1.30 |
2015 | ₹0.68 | -29.2% | ↑ ₹0.95 ↓ ₹0.64 |
2014 | ₹0.96 | 638.4% | ↑ ₹2.75 ↓ ₹0.12 |
2013 | ₹0.13 | -81.5% | ↑ ₹0.71 ↓ ₹0.13 |
2012 | ₹0.70 | - | ↑ ₹0.94 ↓ ₹0.56 |
Analyzing the Impact of Investing in Kashyap Tele-Medicines
Kashyap Tele-Medicines Stock price in the year 2012 was ₹0.70. If you had invested ₹10,000 in Kashyap Tele-Medicines Stock in 2012, in 12 years, your investment would have grown to ₹38,428 by the end of 2024. This represents a positive return of 284% from 2012 to 2024, with a compound annual growth rate (CAGR) of 11.8%.
Kashyap Tele-Medicines Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹3.27 and lowest was: ₹0.12
- Kashyap Tele-Medicines Stock price in 2013 was ₹0.13
- By 2024, its stock price rose to ₹2.69
- It gave a positive return of over 1,969.2% with a CAGR of 83.3% over the last 5 years
- If you had invested ₹10,000 in Kashyap Tele-Medicines in 2013 then in 5 years, your investment would have grown to ₹2.06 Lakh by 2024, which is 20.69 times of your initial investment.
Kashyap Tele-Medicines Returns vs Bank FD Returns
Investment Type | Initial Amount | Final Value | Total Returns |
---|---|---|---|
Kashyap Tele-Medicines Shares | ₹10,000 | ₹38,428.57 | 284.3% |
Bank FD (Simple Interest) | ₹10,000 | ₹17,200 | 72.0% |
Bank FD (Compound Interest) | ₹10,000 | ₹20,121.96 | 101.2% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.